Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
ROSUVASTATIN
Pharma First Limited
10 Milligram
Film Coated Tablet
2009-10-16
IRISH MEDICINES BOARD ACTS 1995 AND 2006 MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007 (S.I. NO.540 OF 2007) PPA1592/002/001 Case No: 2069114 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to PHARMA FIRST LIMITED UNIT 1A - MONREAD BUSINESS PARK, MONREAD ROAD, NAAS, CO. KILDARE, IRELAND an authorisation, subject to the provisions of the said Regulations, in respect of the product CRESTOR 10MG FILM-COATED TABLETS The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 16/10/2009. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 24/10/2009_ _CRN 2069114_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Crestor 10mg Film-coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10mg of rosuvastatin (as rosuvastatin calcium) Excipient(s): Lactose Monohydrate For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet _Product imported from _Italy Pink coloured, round film-coated tablet with ‘ZD4522’ and 10 engraved on one side and plain on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia) or mixed dyslipidaemia (type IIb) as an adjunct to die Read the complete document